Nutrition Consensus

Evidence sentiment publication

[SALM] Whole foods

Salmon

Last updated Jun 20, 2026 · Updated weekly

Is salmon good for you today?

Mostly yes. The strongest, most consistent signal is that eating oily fish like salmon is associated with lower cardiovascular and stroke risk. The main caveat is that omega-3 supplement trials have been far more equivocal than the dietary evidence, and plenty of reviews still land on 'inconsistent' — but the food-consumption ledger leans clearly favorable.

Additional analyst color: The omega-3 desk is long. Just don't confuse the fish with the capsule.

Current score

+70

Sentiment

Strongly positive

Confidence

70 / 100

Controversy

9 / 100

Settled

Evidence items

48

30D0
90D0
1Y0

The seafood desk is long oily fish: prospective cohorts and meta-analyses repeatedly tie higher fish intake to lower coronary, stroke, and mortality risk. Short interest comes from null omega-3 supplement trials and reviewers who keep writing 'inconsistent' — but those test capsules, not dinner.

Analyst noteConfidence is fair, and deliberately not higher: the favorable signal rests on numerous prospective cohorts and meta-analyses pointing the same way, but they are observational and prone to residual socioeconomic/healthy-user confounding — people who eat salmon tend to be richer and healthier to begin with. The cleaner, confounding-free evidence (randomized omega-3 trials) is more equivocal, which is why this is not scored as a slam dunk.

Last meaningful move

Jun 2022

Score move

+5

points

Driven by

Fish and human health: an umbrella review of observational studies.

International journal of food sciences and nutrition · Jun 26, 2022 · Positive · index impact +14

This study carried one of the largest positive public impacts added to the ledger around the move.

View study ->

Evidence sentiment index

Historical price of the salmon thesis

Start
End
-500+50+100Zero line: mixed
Latest+70
SignalStrongly positive
Confidence70 / 100

Axis fitted: -50 to +100. Index scale remains -100 to +100.

Latest studies

Evidence tape

Sorted by publication date, newest first.

Did we miss a study?

Showing 3 of 48 studies after filter and sort.

expert commentary

Omega-3 fatty acids in primary and secondary prevention of cardiovascular diseases.

Progress in cardiovascular diseases · Mar 27, 2024Open study
Direction: PositiveIndex impact +1

Auto-draft (PubMed): abstract suggests a mixed signal. Even with substantial progress in primary and secondary prevention, cardiovascular disease (CVD) persists as a major cause of mortality and morbidity globally.

Limitations: Auto-generated from abstract only. Review full paper for confounding, population characteristics, endpoint definitions, and study design before publishing.

Evidence weight 2 / 100pubmedjournal-articlereviewdoi:10.1016/j.pcad.2024.03.009pmid:38547956

meta analysis

Circulating Docosahexaenoic Acid and Risk of All-Cause and Cause-Specific Mortality.

Mayo Clinic proceedings · Mar 20, 2024Open study
Direction: PositiveIndex impact +20

Auto-draft (PubMed): abstract suggests a favorable signal. OBJECTIVE: To assess the associations of docosahexaenoic acid (DHA), a marine omega-3 fatty acid, with long-term all-cause mortality, cardiovascular (CV) mortality, and cancer mortality.

Limitations: Auto-generated from abstract only. Review full paper for confounding, population characteristics, endpoint definitions, and study design before publishing.

Evidence weight 29 / 100pubmedmeta-analysisjournal-articledoi:10.1016/j.mayocp.2023.11.026pmid:38506781

expert commentary

Long chain n-3 polyunsaturated fatty acid intake across the life span for cardiovascular disease prevention in women.

The Proceedings of the Nutrition Society · Mar 6, 2024Open study
Direction: NeutralIndex impact 0

Auto-draft (SemanticScholar): abstract suggests a unfavorable signal. Cardiovascular diseases (CVD) are a major health concern for women.

Limitations: Auto-generated from abstract only. Review full paper for confounding, population characteristics, endpoint definitions, and study design before publishing.

Evidence weight 2 / 100semanticscholarreviewjournalarticledoi:10.1017/S0029665124000181pmid:38444046

Showing 3 of 48 studies.